Total Credits: .25 including .25 AOA Category 1-A Credit(s)
First presented at the OPSO Annual Primary Care Conference on September 28, 2019.
Learning Objectives
Following the completion of this program, participants will be more familiar with insulin delivery devices available, be able to identify patients who could benefit,
refer to specialist for initiation, obtain additional training and vendor support for personal utilization in their clinical practice, and review current and future
advancements in technology and Diabetes Treatment
Dr. Miller discloses that she has a financial affiliation with any Abbott Pharmaceutical's PCP Board.
The Osteopathic Physicians and Surgeons of Oregon is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of .25 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
Grievance Policy:
All grievances may be directed to OPSO Executive Director at info@opso.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
| Miller, Eden - Diabetes & Pump Technology (1.37 MB) | Available after Purchase | ||
Eden Miller, DO, is an osteopathic board certified Family Practitioner, received her medical degree from Kirksville College of Osteopathic Medicine in 1997. Returning to the Northwest, she completed her residency in family practice at East Moreland Hospital in Portland, Oregon. Dr. Miller is a Diplomat of the American Board of Obesity Medicine. She is the founder of Diabetes Nation, a non profit organization, and CEO of Diabetes and Obesity Care, where she practices in Bend, Oregon, with her husband Kevin Miller, DO. They specialize in diabetes management from diet and exercise intervention, to medication and insulin therapy, insulin pump technology and continuous glucose monitoring. Additional endocrine conditions include: Thyroid disease management, Gestational Diabetes and Osteoporosis.
|
Linking Pain, Trauma, and Substance Abuse, A Behavioral Health Primer
Original Program Date: 09/27/2019 |
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|